Jonathan Treisman
Impact in
- Immunology top 5%
- Immunotherapy and Immune Responses
- Immune Cell Function and Interaction
- T-cell and B-cell Immunology
- Oncology top 5%
- CAR-T cell therapy research
- Cancer Immunotherapy and Biomarkers
Papers in
- Oncology 20
- CAR-T cell therapy research 13
- Cancer Immunotherapy and Biomarkers 6
- Immunology 12
- Immunotherapy and Immune Responses 8
- Immune Cell Function and Interaction 6
- T-cell and B-cell Immunology 3
- Co-authors
- R Cowherd (4 shared papers)GE Shafer (3 shared papers)Zelig Eshhar (5 shared papers)Steven A. Rosenberg (3 shared papers)Patrick Hwu (4 shared papers)Patrick Hwu (2 shared papers)Dvorit Samid (2 shared papers)Brett A. Johnson (1 shared paper)
- Journals
- Journal of Clinical Oncology (3 papers)Blood (2 papers)Gene Therapy (2 papers)Cytometry Part A (1 paper)Human Gene Therapy (1 paper)
- Partner nations
- United StatesIsraelUnited Kingdom
In The Last Decade
Jonathan Treisman
31 papers receiving 1.1k citations
Peers
Comparison fields: 5 of 67
- Immunology 602
- Oncology 675
- Genetics 243
- Radiology, Nuclear Medicine and Imaging 147
- Molecular Biology 425
Countries citing papers authored by Jonathan Treisman
This map shows the geographic impact of Jonathan Treisman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jonathan Treisman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jonathan Treisman more than expected).
Fields of papers citing papers by Jonathan Treisman
This network shows the impact of papers produced by Jonathan Treisman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jonathan Treisman. The network helps show where Jonathan Treisman may publish in the future.
Co-authors
The 25 scholars most cited alongside Jonathan Treisman, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 31 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Expression of the MAGE-1 tumor antigen is up-regulated by the demethylating agent 5-aza-2'-deoxycytidine. | 1994 | 261 |
| 2 | In vivo antitumor activity of T cells redirected with chimeric antibody/T-cell receptor genes. | 1995 | 226 |
| 3 | 1993 | 207 | |
| 4 | 1995 | 65 | |
| 5 | 2000 | 46 | |
| 6 | 2019 | 41 | |
| 7 | 2001 | 32 | |
| 8 | 2016 | 28 | |
| 9 | 1991 | 26 | |
| 10 | 2004 | 24 | |
| 11 | 2011 | 21 | |
| 12 | 2009 | 17 | |
| 13 | Enhancement by interleukin 4 of interleukin 2- or antibody-induced proliferation of lymphocytes from interleukin 2-treated cancer patients. | 1990 | 14 |
| 14 | 1995 | 13 | |
| 15 | 2012 | 12 | |
| 16 | 1994 | 11 | |
| 17 | 2002 | 11 | |
| 18 | 2011 | 10 | |
| 19 | 2005 | 9 | |
| 20 | 1995 | 9 |
About Jonathan Treisman
Jonathan Treisman is a scholar working on Oncology, Immunology, Pulmonary and Respiratory Medicine, Molecular Biology and Epidemiology, having authored 31 papers that have together received 1.1k indexed citations. Recurring topics across this work include CAR-T cell therapy research (13 papers), Immunotherapy and Immune Responses (8 papers), Immune Cell Function and Interaction (6 papers), Cancer Immunotherapy and Biomarkers (6 papers), Virus-based gene therapy research (4 papers), Renal cell carcinoma treatment (4 papers), Monoclonal and Polyclonal Antibodies Research (4 papers) and T-cell and B-cell Immunology (3 papers). The work is most often cited by research in Immunology (602 citations), Oncology (675 citations), Genetics (243 citations), Radiology, Nuclear Medicine and Imaging (147 citations) and Molecular Biology (425 citations). Jonathan Treisman has collaborated with scholars based in United States, Israel and United Kingdom. Frequent co-authors include R Cowherd, GE Shafer, Zelig Eshhar, Steven A. Rosenberg, Patrick Hwu, Patrick Hwu, Dvorit Samid, Brett A. Johnson, Norman J. Lassam and S A Rosenberg. Their work appears in journals such as Journal of Clinical Oncology, Blood, Gene Therapy, Cytometry Part A and Human Gene Therapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.